Recent developments in ex vivo platelet production

Retno Wahyu Nurhayati, Yoshihiro Ojima, Masahito Taya

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


The platelet is a component of blood that functions to initiate blood clotting. Abnormal platelet count and function can lead to a life-threatening condition caused by excessive bleeding. At present, platelet supply for transfusion can be obtained only from platelet donation. However, platelets cannot be stored for longer than 7 days, meaning that routine isolation is required to maintain platelet supply for transfusion. To mitigate for potential platelet shortages, several strategies have been proposed to generate platelets ex vivo. By employing both of natural and artificial approaches, several researchers have successfully generated biomaterials with characteristics similar to human-derived platelets. Their reports indicated that the biomaterials could mimic the aggregation of human-isolated platelets, further suggesting the possibility to substitute or complement human-isolated platelets. The current review summarizes the progress in ex vivo platelet production and gives a prospect for the possible approaches to achieving a feasible platelet factory, based on the Good Manufacturing Practice standards.

Original languageEnglish
Pages (from-to)2211-2221
Number of pages11
Issue number6
Publication statusPublished - 1 Dec 2016


  • Ex vivo production
  • Immortalized cells
  • Megakaryocytes
  • Megakaryopoiesis
  • Platelets


Dive into the research topics of 'Recent developments in ex vivo platelet production'. Together they form a unique fingerprint.

Cite this